SIM
LOXO

Spark Investment Management’s Loxo Oncology, Inc LOXO Stock Holding History

Spark Investment Management’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-68,100
Closed -$9.54M – 782
2018
Q4 		$9.54M Hold
68,100
– – 0.66% 32
2018
Q3 		$11.6M Buy
68,100
+34,300
+101% +$5.76M 0.67% 23
2018
Q2 		$5.86M Buy
+33,800
New +$5.08M 0.34% 87
2017
Q4 		– Sell
-42,500
Closed -$3.92M – 877
2017
Q3 		$3.92M Buy
42,500
+21,400
+101% +$1.66M 0.21% 173
2017
Q2 		$1.69M Buy
+21,100
New +$1.17M 0.1% 286
2016
Q1 		– Sell
-18,800
Closed -$534K – 894
2015
Q4 		$534K Sell
18,800
-35,000
-65% -$939K 0.07% 365
2015
Q3 		$938K Buy
+53,800
New +$1.05M 0.12% 265
2015
Q2 		– Sell
-10,000
Closed -$123K – 790
2015
Q1 		$123K Buy
+10,000
New +$125K 0.02% 601
2014
Q4 		– Sell
-15,400
Closed -$199K – 853
2014
Q3 		$199K Buy
+15,400
New +$200K 0.03% 519

Other funds holding LOXO

IUHSA
Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Spark Investment Management's LOXO Position: Q1 2019 in Review

Spark Investment Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 68,100 shares — an estimated $9.54M sold.

Spark Investment Management first reported a position in LOXO in Q3 2014 and held it in 9 quarters. The position peaked at $11.6M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Spark Investment Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Spark Investment Management sold 68,100 Loxo Oncology, Inc shares in Q1 2019, an estimated $9.54M.
  • Spark Investment Management first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 9 quarters.
  • Spark Investment Management's Loxo Oncology, Inc position peaked at $11.6M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Spark Investment Management's 13F filing for Q1 2019, filed 7 May 2019.